Fcpm Iii Services B.V. Dyne Therapeutics, Inc. Transaction History
Fcpm Iii Services B.V.
- $707 Billion
- Q1 2024
A detailed history of Fcpm Iii Services B.V. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 7,845,364 shares of DYN stock, worth $250 Million. This represents 31.49% of its overall portfolio holdings.
Number of Shares
7,845,364
Previous 6,131,079
27.96%
Holding current value
$250 Million
Previous $81.5 Billion
173.14%
% of portfolio
31.49%
Previous 24.03%
Shares
2 transactions
Others Institutions Holding DYN
# of Institutions
176Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$256 Million28.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$172 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$145 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$136 Million0.02% of portfolio
-
State Street Corp Boston, MA4.19MShares$134 Million0.01% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.65B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...